Literature DB >> 34402140

Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.

Sandra M Hurtado Rúa1, Ulrike W Kaunzner2, Sneha Pandya3, Elizabeth Sweeney4, Ceren Tozlu3, Amy Kuceyeski3,5, Thanh D Nguyen3, Susan A Gauthier2,3,5.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI) provides insight into various pathological processes in multiple sclerosis (MS) and may provide insight into patterns of damage among patients.
OBJECTIVE: We sought to determine if MRI features have clinical discriminative power among a cohort of MS patients.
METHODS: Ninety-six relapsing remitting and seven progressive MS patients underwent myelin water fraction (MWF) imaging and conventional MRI for cortical thickness and thalamic volume. Patients were clustered based on lesion level MRI features using an agglomerative hierarchical clustering algorithm based on principal component analysis (PCA).
RESULTS: One hundred and three patients with 1689 MS lesions were analyzed. PCA on MRI features demonstrated that lesion MWF and volume distributions (characterized by 25th, 50th, and 75th percentiles) accounted for 87% of the total variability based on four principal components. The best hierarchical cluster confirmed two distinct patient clusters. The clustering features in order of importance were lesion median MWF, MWF 25th, MWF 75th, volume 75th percentiles, median individual lesion volume, total lesion volume, cortical thickness, and thalamic volume (all p values <0.01368). The clusters were associated with patient Expanded Disability Status Scale (EDSS) (n = 103, p = 0.0338) at baseline and at 5 years (n = 72, p = 0.0337).
CONCLUSIONS: These results demonstrate that individual MRI features can identify two patient clusters driven by lesion-based values, and our unique approach is an analysis blinded to clinical variables. The two distinct clusters exhibit MWF differences, most likely representing individual remyelination capabilities among different patient groups. These findings support the concept of patient-specific pathophysiological processes and may guide future therapeutic approaches.
© 2021 European Academy of Neurology.

Entities:  

Keywords:  MRI; cluster analysis; lesion; multiple sclerosis; myelin water fraction

Mesh:

Year:  2021        PMID: 34402140      PMCID: PMC8727028          DOI: 10.1111/ene.15067

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  27 in total

1.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

2.  Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.

Authors:  Irene M Vavasour; Sophie C Huijskens; David Kb Li; Anthony L Traboulsee; Burkhard Mädler; Shannon H Kolind; Alexander Rauscher; Gr Wayne Moore; Alex L MacKay; Cornelia Laule
Journal:  Mult Scler       Date:  2017-08-07       Impact factor: 6.312

Review 3.  Association between pathological and MRI findings in multiple sclerosis.

Authors:  Massimo Filippi; Wolfgang Brück; Declan Chard; Franz Fazekas; Jeroen J G Geurts; Christian Enzinger; Simon Hametner; Tanja Kuhlmann; Paolo Preziosa; Àlex Rovira; Klaus Schmierer; Christine Stadelmann; Maria A Rocca
Journal:  Lancet Neurol       Date:  2019-02       Impact factor: 44.182

4.  Oligodendrocyte Intrinsic miR-27a Controls Myelination and Remyelination.

Authors:  Ajai Tripathi; Christina Volsko; Jessie P Garcia; Eneritz Agirre; Kevin C Allan; Paul J Tesar; Bruce D Trapp; Goncalo Castelo-Branco; Fraser J Sim; Ranjan Dutta
Journal:  Cell Rep       Date:  2019-10-22       Impact factor: 9.423

5.  Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions.

Authors:  Sneha Pandya; Ulrike W Kaunzner; Sandra M Hurtado Rúa; Nancy Nealon; Jai Perumal; Timothy Vartanian; Thanh D Nguyen; Susan A Gauthier
Journal:  J Neuroimaging       Date:  2020-06-24       Impact factor: 2.486

6.  Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord.

Authors:  Cheryl R McCreary; Thorarin A Bjarnason; Viktor Skihar; J Ross Mitchell; V Wee Yong; Jeff F Dunn
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

Review 7.  Overcoming remyelination failure in multiple sclerosis and other myelin disorders.

Authors:  Stephen P J Fancy; Mark R Kotter; Emily P Harrington; Jeffrey K Huang; Chao Zhao; David H Rowitch; Robin J M Franklin
Journal:  Exp Neurol       Date:  2010-01-04       Impact factor: 5.330

Review 8.  Multiple Sclerosis: Mechanisms and Immunotherapy.

Authors:  Clare Baecher-Allan; Belinda J Kaskow; Howard L Weiner
Journal:  Neuron       Date:  2018-02-21       Impact factor: 17.173

9.  MRI phenotypes in MS: Longitudinal changes and miRNA signatures.

Authors:  Christopher C Hemond; Brian C Healy; Shahamat Tauhid; Maria A Mazzola; Francisco J Quintana; Roopali Gandhi; Howard L Weiner; Rohit Bakshi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-02-14

10.  Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis.

Authors:  Piet M Bouman; Martijn D Steenwijk; Petra J W Pouwels; Menno M Schoonheim; Frederik Barkhof; Laura E Jonkman; Jeroen J G Geurts
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.